Default company panoramic image


PROTAGEN AG has developed the proprietary UNIarray® platform to support patient stratification and the development of companion diagnostics.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Dortmund, NRW, Deutschland
  • Currency EUR
  • Founded January 1997
  • Employees 29
  • Website

Company Summary

Protagen AG employs the proprietary UNIarray® platform to support clinical studies I-IV. Our approach builds on the systematic and comprehensive autoantibody profiling of patients serum with focus on autoimmune diseases, neurodegenerative disorders, and cancer. Collaboration projects have successfully been performed with Bayer (Endometriosis), Biogen-Idec (MS), and SuppreMol (SLE).